Prostate cancer screening with PSA: new data, old debate
Two prostate cancer screening randomised controlled trials from Europe (European Randomised Study of Screening for Prostate Cancer-ERSPC) and U.S. (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Program- PLCO) have been published earlier this year...
Saved in:
Main Authors: | Stefania Sciallero (Author), Giuseppe Fornarini (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PSA testing for men at average risk of prostate cancer
by: Bruce K Armstrong, et al.
Published: (2017) -
Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: Xin LIU, et al.
Published: (2015) -
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
by: Joanna C. Thorn, et al.
Published: (2023) -
General practitioners' reflections on using PSA for diagnosis of prostate cancer. A qualitative study
by: Olav Thorsen, et al.
Published: (2022) -
Relationship between BMI, PSA and Histopathological Tumor Grade in a Caucasian Population Affected by Prostate Cancer
by: Tirabassi G, et al.
Published: (2014)